首页 | 本学科首页   官方微博 | 高级检索  
检索        

经尿道膀胱肿瘤切除术联合辅助动脉化疗对膀胱癌患者术后控尿、性能力及肿瘤控制效果的影响
引用本文:张钢.经尿道膀胱肿瘤切除术联合辅助动脉化疗对膀胱癌患者术后控尿、性能力及肿瘤控制效果的影响[J].现代肿瘤医学,2021,0(3):437-441.
作者姓名:张钢
作者单位:淄博市第一医院泌尿外科,山东 淄博 255200
摘    要:目的:探讨经尿道膀胱肿瘤切除术(transurethral resection of bladder tumor,TURBT)联合辅助动脉化疗对膀胱癌患者术后控尿、性能力及肿瘤控制效果的影响。方法:选取我院2013年5月至2015年5月收治的92例拟行TURBT术治疗的膀胱癌患者为研究对象,随机分为观察组(46例)和对照组(46例),对照组行TURBT术+术后灌注化疗,观察组行术前动脉化疗+TURBT术+术后灌注化疗,比较两组患者围术期情况和术后不同时间控尿率、勃起功能国际问卷(IIEF-5)评分、复发率、总体生存率(OS)生命质量综合评定问卷(GQOLI-74)评分。结果:观察组术中出血量、手术时间、尿管留置时间和住院天数均明显少于对照组(P<0.05);两组间术后3个月IIEF-5评分无显著差异(P>0.05),观察组术后其他时间点IIEF-5评分和各时间点控尿率均明显高于对照组(P<0.05);两组术后6、12、24个月死亡率比较,无显著差异(P>0.05);观察组术后6、12、24个月躯体功能、社会功能、物质生活、心理功能评分均显著高于对照组(P<0.05)。结论:TURBT术联合辅助动脉化疗可有效控制膀胱癌,提高躯体、社会、心理功能等相关生命质量。

关 键 词:TURBT  动脉化疗  膀胱癌  控尿  性能力  肿瘤控制效果

Effects of transurethral resection of bladder tumor combined with adjuvant arterial chemotherapy on postoperative urinary continence,sexuality and tumor control effects in patients with bladder cancer
ZHANG Gang.Effects of transurethral resection of bladder tumor combined with adjuvant arterial chemotherapy on postoperative urinary continence,sexuality and tumor control effects in patients with bladder cancer[J].Journal of Modern Oncology,2021,0(3):437-441.
Authors:ZHANG Gang
Institution:Department of Urinary Surgery,Zibo First Hospital,Shandong Zibo 255200,China.
Abstract:Objective:To explore the effects of transurethral resection of bladder tumor(TURBT)combined with adjuvant arterial chemotherapy on postoperative urinary continence,sexuality and tumor control effects in patients with bladder cancer.Methods:92 cases of patients with bladder cancer treated with TURBT in our hospital from May 2013 to May 2015 were selected for the study and randomly divided into observation group(n=46)and control group(n=46).Control group was given TURBT+postoperative infusion chemotherapy,and observation group was given preoperative arterial chemotherapy+TURBT surgery+postoperative infusion chemotherapy.The perioperative situation and postoperative urinary continence rate at different times,international index of erectile function questionnaire(IIEF-5)score,recurrence rate,overall survival rate(OS)and general quality of life questionnaire(GQOLI-74)score were compared between the two groups.Results:The intraoperative blood loss,operative time,catheter indwelling time and hospital stay in observation group were significantly less than those in control group(P<0.05).There was no significant difference in the IIEF-5 score at 3 months after operation between the two groups(P>0.05),and the IIEF-5 score and urinary continence rate at other time points after operation were significantly higher in observation group than those in control group(P<0.05).There was no significant difference in the mortality rate between the two groups at 6,12 and 24 months after operation(P>0.05).The scores of physical function,social function,material life and mental function in observation group at 6,12 and 24 months after operation were significantly higher than those in control group(P<0.05).Conclusion:TURBT combined with adjuvant arterial chemotherapy can effectively control the bladder cancer,and improve physical function,social function and psychological function and other related quality of life.
Keywords:TURBT  arterial chemotherapy  bladder cancer  urinary continence  sexuality  tumor control effects
本文献已被 维普 等数据库收录!
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号